Concepedia

A phase II study of capecitabine plus docetaxel in gemcitabine-pretreated metastatic pancreatic cancer patients: CapTere

Heloisa P. Soares, Soley Bayraktar, Marcelo Blaya, Gilberto Lopes, Jaime R. Merchan, Jessica MacIntyre, Carlos Mayo, Mark R. Green, Orlando Silva, Joé U. Levi,

Cancer Chemotherapy and Pharmacology · 2014 · 13 citations · 18 references

DOI

Concepts

References

18

FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer

Thierry Conroy, Françoise Desseigne, Marc Ychou et al. · New England Journal of Medicine · 2011 · 7.8K citations · Full text

, , +13

Superior Survival With Capecitabine Plus Docetaxel Combination Therapy in Anthracycline-Pretreated Patients With Advanced Breast Cancer: Phase III Trial Results

Joyce O’Shaughnessy, David Miles, Svetislava J. Vukelja et al. · Journal of Clinical Oncology · 2002 · 1.1K citations

, , +14

A phase II study

Philippe Rougier, Antoine Adenis, Michel Ducreux et al. · European Journal of Cancer · 2000 · 752 citations

, , +4

Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: A phase III-study from the German CONKO-study group

Uwe Pelzer, Ingo Schwaner, Jens Stieler et al. · European Journal of Cancer · 2011 · 380 citations

, , +10

Capecitabine Plus Erlotinib in Gemcitabine-Refractory Advanced Pancreatic Cancer

Matthew H. Kulke, Lawrence S. Blaszkowsky, David P. Ryan et al. · Journal of Clinical Oncology · 2007 · 167 citations · Full text

, , +15